AGN News and Press, Allergan plc From 12/24/19

Merger activity increased, with nine new deals announced and six deals closing. Deal Statistics New Deals The acquisition of LogMeIn (LOGM) by Francisco Partners for $4.3 billion or $86.05 per share in cash. We added LOGM as a potential deal to the Deals in the Works section on Dece...

Introduction I recently wrote an article about Revance Therapeutics' ( RVNC ) long-acting DAXI (DaxiBotulinumToxinA) and how the Phase III data was compelling enough to make me open a long position in RVNC. As an investor, I think it is paramount to always fully assess any competition that...

Allergan ( AGN +0.5% ) gets U.S. FDA approval for Ubrelvey (ubrogepant) for the acute treatment of migraine with or without aura in adults. More news on: Allergan plc, Healthcare stocks news, Read more ...

DUBLIN , Dec. 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for UBRELVY™ (ubrogepant) for the acute treatment of migraine with or without aura in adults. UBRELVY...

Has there been a lot of hype about CRISPR gene editing ? Absolutely. But while the hype might have been overdone in some cases, the reality is that there's significant potential for CRISPR (which stands for "clustered regularly interspaced short palindromic repeats") to transform the way many d...

THOUSAND OAKS, Calif. , Dec. 19, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 798, a biosimilar candidate to Rituxan ® (r...

IRVINE, Calif. , Dec. 19, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that The Allergan Foundation has awarded a total of $10 million in charitable grants in 2019. The grants were donated to more than 400 organizations in 32 st...

The global migraine market is estimated to reach $7.8 billion in the year 2025. This makes the current competition interesting and contributes to the development of new drugs to treat this condition. Although there is an opinion about the market becoming overcrowded; in my point of view,...

The Trump administration has announced a pilot project allowing states and non-federal government entities to import certain medicines from Canada which pays much lower prices under its single-payer system. More news on: Health Care Select Sect SPDR ETF, SPDR Biotech ETF, Invesco Exchang...

DUBLIN , Dec. 16, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) is commemorating today the beginning of the 30 th anniversary celebration for BOTOX ® this year with the ringing of the New York Stock Exchange opening bell. Over the past 30 years, more than 100 million vials of ...